Literature DB >> 17346118

Target specific compound identification using a support vector machine.

Dariusz Plewczynski1, Marcin von Grotthuss, Stephane A H Spieser, Leszek Rychlewski, Lucjan S Wyrwicz, Krzysztof Ginalski, Uwe Koch.   

Abstract

In many cases at the beginning of an HTS-campaign, some information about active molecules is already available. Often known active compounds (such as substrate analogues, natural products, inhibitors of a related protein or ligands published by a pharmaceutical company) are identified in low-throughput validation studies of the biochemical target. In this study we evaluate the effectiveness of a support vector machine applied for those compounds and used to classify a collection with unknown activity. This approach was aimed at reducing the number of compounds to be tested against the given target. Our method predicts the biological activity of chemical compounds based on only the atom pairs (AP) two dimensional topological descriptors. The supervised support vector machine (SVM) method herein is trained on compounds from the MDL drug data report (MDDR) known to be active for specific protein target. For detailed analysis, five different biological targets were selected including cyclooxygenase-2, dihydrofolate reductase, thrombin, HIV-reverse transcriptase and antagonists of the estrogen receptor. The accuracy of compound identification was estimated using the recall and precision values. The sensitivities for all protein targets exceeded 80% and the classification performance reached 100% for selected targets. In another application of the method, we addressed the absence of an initial set of active compounds for a selected protein target at the beginning of an HTS-campaign. In such a case, virtual high-throughput screening (vHTS) is usually applied by using a flexible docking procedure. However, the vHTS experiment typically contains a large percentage of false positives that should be verified by costly and time-consuming experimental follow-up assays. The subsequent use of our machine learning method was found to improve the speed (since the docking procedure was not required for all compounds from the database) and also the accuracy of the HTS hit lists (the enrichment factor).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346118     DOI: 10.2174/138620707780126705

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  16 in total

1.  Computational structure-activity relationship analysis of small-molecule agonists for human formyl peptide receptors.

Authors:  Andrei I Khlebnikov; Igor A Schepetkin; Mark T Quinn
Journal:  Eur J Med Chem       Date:  2010-09-15       Impact factor: 6.514

2.  kNNsim: k-nearest neighbors similarity with genetic algorithm features optimization enhances the prediction of activity classes for small molecules.

Authors:  Dariusz Plewczynski
Journal:  J Mol Model       Date:  2008-07-29       Impact factor: 1.810

3.  Nature is the best source of anti-inflammatory drugs: indexing natural products for their anti-inflammatory bioactivity.

Authors:  Miran Aswad; Mahmoud Rayan; Saleh Abu-Lafi; Mizied Falah; Jamal Raiyn; Ziyad Abdallah; Anwar Rayan
Journal:  Inflamm Res       Date:  2017-09-27       Impact factor: 4.575

4.  VoteDock: consensus docking method for prediction of protein-ligand interactions.

Authors:  Dariusz Plewczynski; Michał Łaźniewski; Marcin von Grotthuss; Leszek Rychlewski; Krzysztof Ginalski
Journal:  J Comput Chem       Date:  2010-09-01       Impact factor: 3.376

5.  Brainstorming: weighted voting prediction of inhibitors for protein targets.

Authors:  Dariusz Plewczynski
Journal:  J Mol Model       Date:  2010-09-21       Impact factor: 1.810

Review 6.  Understanding nuclear receptors using computational methods.

Authors:  Ni Ai; Matthew D Krasowski; William J Welsh; Sean Ekins
Journal:  Drug Discov Today       Date:  2009-03-11       Impact factor: 7.851

7.  A multi-label approach to target prediction taking ligand promiscuity into account.

Authors:  Hamse Y Mussa; Andreas Bender; Avid M Afzal; Richard E Turner; Robert C Glen
Journal:  J Cheminform       Date:  2015-05-30       Impact factor: 5.514

8.  Diverse models for anti-HIV activity of purine nucleoside analogs.

Authors:  Naveen Khatri; Viney Lather; A K Madan
Journal:  Chem Cent J       Date:  2015-05-23       Impact factor: 4.215

9.  The influence of the inactives subset generation on the performance of machine learning methods.

Authors:  Sabina Smusz; Rafał Kurczab; Andrzej J Bojarski
Journal:  J Cheminform       Date:  2013-04-05       Impact factor: 5.514

10.  Connecting proteins with drug-like compounds: Open source drug discovery workflows with BindingDB and KNIME.

Authors:  George Nicola; Michael R Berthold; Michael P Hedrick; Michael K Gilson
Journal:  Database (Oxford)       Date:  2015-09-16       Impact factor: 3.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.